Waldencast Acquisition Corp. (NASDAQ:WALDU) saw a large drop in short interest in August. As of August 31st, there was short interest totalling 2,800 shares, a drop of 62.2% from the August 15th total of 7,400 shares. Based on an average daily trading volume, of 27,700 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the shares of the company are short sold.
WALDU stock opened at $10.15 on Friday. Waldencast Acquisition has a twelve month low of $9.52 and a twelve month high of $10.98. The company’s 50-day moving average is $10.21.
Get Waldencast Acquisition alerts:
A number of large investors have recently added to or reduced their stakes in WALDU. Boothbay Fund Management LLC bought a new position in Waldencast Acquisition in the 2nd quarter valued at $119,000. Virtu Financial LLC purchased a new stake in shares of Waldencast Acquisition during the 1st quarter worth $125,000. Wealthspring Capital LLC purchased a new stake in shares of Waldencast Acquisition during the 1st quarter worth $168,000. GABELLI & Co INVESTMENT ADVISERS INC. purchased a new stake in shares of Waldencast Acquisition during the 1st quarter worth $194,000. Finally, Susquehanna International Group LLP lifted its stake in shares of Waldencast Acquisition by 36.7% during the 2nd quarter. Susquehanna International Group LLP now owns 19,716 shares of the company’s stock worth $203,000 after purchasing an additional 5,288 shares during the last quarter.
Best Financial Stocks To Watch For 2021: CVD Equipment Corporation(CVV)
CVD Equipment Corporation designs, develops, and manufactures custom and standard equipment and process solutions used to develop and manufacture solar, nano, and advanced electronic components, materials, and coatings for research and industrial applications in the United States and internationally. It operates through two divisions, CVD/First Nano and Stainless Design Concepts. The company offers chemical vapor deposition systems for use in the research, development, and manufacture of semiconductors, LEDs, carbon nanotubes, nanowires, solar cells, LEDs, MEMS, and other industrial applications; and rapid thermal processing systems for implant activation, oxidation, silicide formation, and other processes. It also provides annealing and diffusion furnaces for use in diffusion, oxidation, implant anneal, solder reflow, solar cell manufacturing, and other processes; and gas and chemical delivery control systems for semiconductor fabrication processes, solar cells, LEDs, carbon nanotubes, nanowires, and various industrial applications. In addition, it provides standard and custom fabricated quartz ware used in its equipment and other customer tools. The company sells its products primarily to electronic component manufacturers, universities, government, and industrial laboratories, as well as industries, such as aerospace that require specialized coatings. CVD Equipment Corporation was founded in 1982 and is based in Central Islip, New York.
- [By Ethan Ryder]
News headlines about CVD Equipment (NASDAQ:CVV) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. CVD Equipment earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news stories about the industrial products company an impact score of 46.7103888113407 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
- [By Shane Hupp]
News coverage about CVD Equipment (NASDAQ:CVV) has been trending somewhat positive this week, according to Accern. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CVD Equipment earned a news impact score of 0.07 on Accern’s scale. Accern also assigned news headlines about the industrial products company an impact score of 47.2607770405573 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Best Financial Stocks To Watch For 2021: Ionis Pharmaceuticals, Inc.(IONS)
Ionis Pharmaceuticals, Inc., a RNA-targeted drug discovery and development company, develops drugs for patients with severe and rare diseases in the United States. The company markets KYNAMRO for the treatment of homozygous familial hypercholesterolemia, and Alicaforsen for ulcerative colitis and pouchitis. Its drugs in Phase III development include Nusinersen for the treatment of patients with spinal muscular atrophy; IONIS-TTRRx for the treatment of patients with various forms of TTR amyloidosis, including familial amyloid polyneuropathy, familial amyloid cardiomyopathy, and wild-type TTR amyloidosis; volanesorsen for the treatment of patients with familial chylomicronemia syndrome and familial partial lipodystrophy; Custirsen to treat cancer; and Plazomicin for the treatment of severe bacterial infection. The companys products under development also include IONIS-DMPK-2.5 for myotonic dystrophy type 1; IONIS-HTT for huntington’s disease; ATL1103 for acromegaly; IONIS-SOD1 for amyotrophic lateral sclerosis; IONIS-FXI (BAY 2306001) for clotting disorders; IONIS-APO(a)-L for high Lp; IONIS-ANGPTL3-L for mixed dyslipidemias; Apatorsen (OGX-427) and IONIS-STAT3-2.5 (AZD9150) for cancer; EXC 001 (PF-06473871) for scarring; ATL1102 for multiple sclerosis; RG-101 for hepatitis C virus infection; IONIS-GCGR and IONIS-PTP1B for type 2 diabetes; and IONIS-FGFR4 for obesity. In addition, it is developing IONIS-GCCR for cushing’s syndrome; IONIS-PKK for hereditary angioedema; RG-012 for alport syndrome; IONIS-AR-2.5 (AZD5312) for prostate cancer; IONIS-GSK4-L for ocular disease; IONIS-HBV and IONIS-HBV-L for hepatitis B virus infection; and IONIS-DGAT2 for nonalcoholic steatohepatitis. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.
- [By ]
Ionis Pharmaceuticals (Nasdaq: IONS), just a tad bigger than Sarepta, is another potential takeover candidate. Founded in 1989 and public since 1991, IONS, unlike many of its peers, has already broke even (in 2017), and expects to remain profitable from now on. On top of this, IONS has more than $2 billion in cash and equivalents on the balance sheet.
- [By Max Byerly]
Ionis Pharmaceuticals Inc (NASDAQ:IONS) Director B Lynne Parshall sold 8,334 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $75.00, for a total transaction of $625,050.00. Following the completion of the transaction, the director now owns 61,011 shares of the company’s stock, valued at $4,575,825. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Best Financial Stocks To Watch For 2021: Golfsmith International Holdings Inc.(GOLF)
Golfsmith International Holdings, Inc. operates as a specialty retailer of golf and tennis equipment, apparel, footwear, and accessories. Its stores offer branded clubs, balls, apparel, and accessories, as well as its proprietary-branded products, including Clubmaker, Golfsmith, Killer Bee, J.G.Hickory, Lynx, Profinity, Snake Eyes, TourTrek, XPC, Zevo, Maggie Lane, ZTech, and MacGregor. The company?s stores also provide club components, clubmaking tools, supplies and on-site clubmaking, custom club-fitting, and club repair services; and hitting areas, putting greens, ball-launch monitor technology, and club demos. In addition, its stores offer golf and tennis lessons, tennis equipment, and tennis racquet maintenance and repair services, as well as partial-flight indoor driving ranges. Further, the company develops and promotes proprietary merchandise, including clubs, club components, apparel, golf bags and covers, pull and push carts, shoes, furnishings, accessories, tra ining aids, and gifts. As of January 25, 2012, it operated 79 stores in the United States. Golfsmith International Holdings also offers its products through catalog and Internet sales. The company was founded in 1967 and is headquartered in Austin, Texas.
- [By Will Ashworth]
Acushnet (NYSE:GOLF) is the second of five stocks to buy instead of GME. It currently trades around $50 and generates $391.0 million in TTM FCF. Acushnet has 73.91 million shares outstanding for $5.29 TTM FCF per share. It trades at 9.5x TTM FCF compared to 185.7x TTM FCF for GameStop.
- [By Joseph Griffin]
Golfcoin (CURRENCY:GOLF) traded down 11.2% against the dollar during the 24-hour period ending at 10:00 AM E.T. on October 4th. Over the last week, Golfcoin has traded down 59.6% against the dollar. One Golfcoin coin can now be bought for about $0.0001 or 0.00000001 BTC on popular cryptocurrency exchanges. Golfcoin has a market capitalization of $114,793.00 and $48.00 worth of Golfcoin was traded on exchanges in the last 24 hours.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Acushnet (GOLF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com